| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210634 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 14 Pages |
Abstract
Antitumor immunity may depend on maintenance of a sufficiently high number of activated CTLs during HPT in HCC patients and CD4+ CD25+ T cells and CD4+ CD127+ T cells prior to treatment in ICC patients. These results could guide the design of future studies to determine the optimal treatment schedules when combining irradiation with specific immunotherapy approaches.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Clemens PhD, Theodore S. MD, Tai MD, PhD, Beow Y. ScD, Jennifer Y. MD, Mark BSc, Thomas PhD, John A. PhD, Christine E. MD, Lipika MD, Jeffrey W. MD, Christopher H. MD, Eugene J. MD, PhD, Mark MD, PhD, Thomas F. MD, Rakesh K. PhD, Andrew X. MD, PhD,